Jump to content

SCQ1

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
SCQ1
Identifiers
  • (S)-spiro[4-azabicyclo[2.2.2]octane-2,2'-benzo[h]chromen]-4'(3'H)-one
ChemSpider
Chemical and physical data
FormulaC19H19NO2
Molar mass293.366 g·mol−1
3D model (JSmol)
  • O=C3C[C@@]1(CN2CCC1CC2)Oc4c3ccc5ccccc45

(S)-SCQ1 is a drug which acts as a potent and selective antagonist for the 5-HT2B and 5-HT2C serotonin receptors, but with only modest affinity for the closely related 5-HT2A receptor and other targets such as 5-HT7. Since most currently available 5-HT2 class ligands have relatively poor selectivity and bind to all three subtypes, the selectivity of (S)-SCQ1 is expected to be useful for studying 5-HT2A receptor mediated responses in the absence of 5-HT2B and 5-HT2C activation.[1]

See also

References

  1. ^ Yao R, Jensen AA, Bryce-Rogers HP, Schultz-Knudsen K, Zhou L, Hovendal NP, et al. (August 2023). "Identification of 5-HT2 Serotonin Receptor Modulators through the Synthesis of a Diverse, Tropane- and Quinuclidine-alkaloid-Inspired Compound Library". Journal of Medicinal Chemistry. 66 (16): 11536–11554. doi:10.1021/acs.jmedchem.3c01059. PMID 37566000. S2CID 260806387.